PTC Therapeutics
Email page Email Page  Print Page Print Page  Contact Us   Text Size
A  A  A
 Leadership
 Senior Management
Stuart W. Peltz, Ph.D.
William Baird, III
Neil Almstead, Ph.D.
Kurt Andrews
John Babiak, Ph.D.
Mark E. Boulding
Joseph M. Colacino, Ph.D.
Cláudia Hirawat
Clare Kennedy
Manal Morsy, M.D., Ph.D.
Theresa Natalicchio
 Board of Directors
 Scientific Advisory Board
 Collaborations
 Working at PTC
Neil Almstead, Ph.D.

Senior Vice President, Research and CMC
Neil Almstead, Ph.D. joined PTC in 2000, and is responsible for PTC's efforts in research and manufacturing. Dr. Almstead joined PTC from Procter & Gamble (P&G) where he was directly involved in the areas of inflammatory diseases and oncology. At P&G he was project leader for both the Matrix Metalloproteinase and Map kinase inhibitor projects. Dr. Almstead has coauthored more than 75 publications and patents pertaining to the design and synthesis of lead candidate compounds for genetic disorders, oncology and inflammatory diseases. After receiving his Ph.D. in Organic Chemistry from the University of Illinois at Urbana-Champaign under the direction of Professor Scott Denmark, Dr. Almstead was a postdoctoral associate at the University of Basel in Switzerland with Professor Bernd Giese.

Neil Almstead, Ph.D.